View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
January 15, 2016

Clinical Trial suspended after one patient dies

A clinical trial taking place in France is halted after one patient dies and five are left critically ill

By Staff Writer

A clinical trial taking place in the French city of Rennes has left one patient dead and five critically ill, according to media reports.

The study, being conducted by a CRO, was a Phase 1 trial involving healthy volunteers. It is believed the accident occurred on Thursday.

Initially, it was reported the drug on trial was a cannabis-based painkiller. However, the French health ministry has denied that was the case.

As it stands, the trial has been suspended, with the firm conducting the trial recalling all 90 volunteers that took part.

According to the BBC, the Paris prosecutor’s office has opened up an investigation. Additionally, France’s Health Minister Marisol Touraine has vowed to "get to the bottom of this tragic accident."

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena